Proof of Usefulness Report

Ryah Group Inc.

Analysis completed on 1/24/2026

+39
Proof of Usefulness Score
You're In Business

RYAH Group Inc. is a verifiable medical technology company with legitimate hardware (Smart Inhaler) and patents, evidenced by external ISO 13485 certifications and past stock listings (CSE: RYAH). However, the project evaluation is severely impacted by the poor quality of this submission, which contains demonstrably false and hyperbolic claims (e.g., 'most people have used my product' and audience reach of 'everyone'). While the underlying technology has merit and utility in the medical cannabis sector, the company appears to be a struggling micro-cap with minimal current traction compared to the submission's claims. The score reflects the existence of valid technology weighed against a lack of serious engagement in the submission and weak market performance.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+18.75
Audience Reach Impact+0.50
Technical Innovation+12.00
Evidence Of Traction+1.88
Market Timing Relevance+3.00
Functional Completeness+0.13
Subtotal+36.26
Usefulness Multiplierx1.08
Final Score+39

Project Details

Project URL
Description
RYAH™ is a global technology company focused on Big Data fed by its IoT-ecosystem of connected devices (Inhalers and Patches) and apps uniquely enabling valuable AI-powered predictive analytics of the efficacy of plant-based remedies including cannabis, and other drugs or nutraceuticals.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline